查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1518814

数位病理市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

Digital Pathology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 249 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球数位病理市场的综合报告。该报告全面评估了主要市场动态，包括驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

重要见解

  • 数位病理市场规模（2024年）：81亿美元
  • 预计市值（2031年）：195亿美元
  • 全球市场成长率（2024-2031年复合年增长率）：13.5%

数位病理学市场—研究范围：

数位病理学涉及在数位环境中捕获、管理、共享和解释病理资讯。数位病理学系统使用透过扫瞄传统载玻片创建的虚拟载玻片来提供高解析度影像以进行分析和诊断。这项技术对于各种应用都极为重要，包括初级诊断、诊断咨询、临床研究和教育目的。该市场为医院、诊断实验室、学术研究机构和製药公司提供服务，提供各种系统和解决方案，包括全玻片成像 (WSI)、影像分析软体以及储存和通讯解决方案。

市场成长动力：

全球数位病理市场由几个关键因素推动，包括扩大采用旨在提高诊断准确性和工作流程效率的数位病理系统。癌症等慢性疾病的盛行率不断上升，需要准确、及时的诊断，从而推动了对数位病理解决方案的需求。人工智慧 (AI) 和机器学习 (ML) 的整合等技术进步正在提高影像分析和诊断能力并推动市场成长。此外，对个人化医疗的日益关注以及能够实现远距诊断和咨询的远距病理学服务的扩展正在为市场扩张创造新的途径。

市场限制因素：

儘管成长前景广阔，但数位病理市场面临高实施成本、资料安全问题和监管合规性等课题。数位病理系统（例如扫瞄器、软体和 IT 基础设施）所需的高额初始投资是采用的障碍，特别是对于中小型实验室而言。此外，考虑到患者资讯的敏感性，确保数位病理数据的安全性和机密性至关重要。监管标准和合规要求因地区而异，使市场准入和营运流程变得复杂。为了解决这些经济和监管障碍，行业利益相关者和政策制定者必须共同努力，以促进获得安全且具有成本效益的数位病理解决方案。

市场机会：

在技术创新、人口趋势和不断发展的医疗保健服务模式的推动下，数位病理市场提供了巨大的成长机会。人工智慧和机器学习技术在数位病理诊断中的整合提高了诊断准确性，自动化日常任务，促进预测分析，并开闢了精准医学的新领域。在通讯基础设施的进步和远端诊断解决方案的需求的推动下，远端病理诊断的上升趋势扩大了市场范围和可及性。战略合作伙伴关係、研发投资以及引入用户友好且可互通的数位病理系统对于利用新的商机并保持动态数位病理领域的市场领先地位至关重要。

本报告解决的关键问题

  • 推动数位病理市场全球成长的关键因素是什么？
  • 哪些系统和应用程式正在推动数位病理学在不同医疗保健环境中的采用？
  • 技术进步如何改变数位病理市场的竞争格局？
  • 谁是数位病理学市场的关键参与者？
  • 全球数位病理市场有哪些新趋势和未来前景？

目录

第1章 内容提要

第2章 市场概况

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
    • 主要趋势
  • 产品类型生命週期分析
  • 数位病理市场：价值链
    • 原材料供应商名单
    • 製造商名单
    • 经销商名单
    • 用途一览
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 世界GDP成长展望
    • 全球母公司市场概览
  • 预测变量 - 相关性和影响
  • 监管和技术格局

第3章 全球数位病理市场展望：实际结果（2019-2023）与预测（2024-2031）

  • 主要亮点
    • 市场规模（单位）预测
    • 市场规模及年成长率
    • 绝对数量机会
  • 市场规模分析及预测（十亿美元）
    • 过去的市场规模分析，2019-2023
    • 目前市场规模预测，2024-2031
  • 全球数位病理市场展望：产品类型
    • 简介/主要发现
    • 2019-2023 年依产品类型划分的历史市场规模（十亿美元）和数量（单位）分析
    • 2024-2031 年依产品类型划分的当前市场规模（十亿美元）和销售（单位）预测
  • 市场吸引力分析：产品类型
  • 全球数位病理市场展望：应用
    • 简介/主要发现
    • 2019-2023 年依应用划分的历史市场规模（十亿美元）和数量（单位）分析
    • 2024-2031 年依应用划分的当前市场规模（十亿美元）和数量（单位）预测
  • 市场吸引力分析：应用
  • 全球数位病理市场展望：最终用户
    • 简介/主要发现
    • 2019-2023 年最终用户历史市场规模（十亿美元）与数量（单位）分析
    • 2024-2031 年最终用户当前市场规模（十亿美元）和数量（单位）预测
  • 市场吸引力分析：最终用户

第4章 全球数位病理市场展望：地区

  • 主要亮点
  • 2019-2023 年依地区历史市场规模（十亿美元）和数量（单位）分析
  • 2024-2031 年依地区划分的当前市场规模（十亿美元）和销售量（单位）预测
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：区域

第5章 北美数位病理市场展望：实际（2019-2023）与预测（2024-2031）

第6章 欧洲数位病理市场展望：实际（2019-2023）与预测（2024-2031）

第7章 东亚数位病理市场展望：实际（2019-2023）与预测（2024-2031）

第8章 南亚和大洋洲数位病理市场展望：实际结果（2019-2023）和预测（2024-2031）

第9章 拉丁美洲数位病理市场展望：实际（2019-2023）与预测（2024-2031）

第10章 中东和非洲数位病理市场展望：实际（2019-2023）和预测（2024-2031）

第11章 竞争格局

  • 2024 年市场占有率分析
  • 市场结构
    • 竞争加剧地图：依市场划分
    • 有竞争力的模拟IC
    • 表观产品类型容量
  • 公司简介（详细资讯 - 概述、财务状况、策略、最新发展）
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Huron Technologies International Inc.
    • Koninklijke Philips NV
    • Olympus Corporation
    • Hamamatsu Photonics KK
    • Carl Zeiss AG
    • Nikon Corporation
    • 3DHISTECH Ltd.
    • Hologic Inc.
    • PerkinElmer, Inc.
    • Visiopharm
    • OptraSCAN, Inc.
    • Inspirata, Inc.
    • Sectra AB

第12章 附录

  • 调查方法
  • 调查先决条件
  • 缩写
简介目录
Product Code: PMRREP33922

Persistence Market Research has recently released a comprehensive report on the worldwide market for digital pathology. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Digital Pathology Market Size (2024E): USD 8.1 Bn
  • Projected Market Value (2031F): USD 19.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 13.5%

Digital Pathology Market - Report Scope:

Digital pathology involves the acquisition, management, sharing, and interpretation of pathology information in a digital environment. Digital pathology systems use virtual slides created by scanning conventional glass slides and provide high-resolution images for analysis and diagnosis. This technology is pivotal in various applications, including primary diagnosis, diagnostic consultation, clinical research, and educational purposes. The market caters to hospitals, diagnostic laboratories, academic and research institutions, and pharmaceutical companies, offering a range of systems and solutions, such as whole slide imaging (WSI), image analysis software, and storage and communication solutions.

Market Growth Drivers:

The global digital pathology market is propelled by several key factors, including the growing adoption of digital pathology systems to enhance diagnostic accuracy and workflow efficiency. The rising prevalence of chronic diseases, such as cancer, necessitates accurate and timely diagnosis, driving demand for digital pathology solutions. Technological advancements, such as artificial intelligence (AI) and machine learning (ML) integration, improve image analysis and diagnostic capabilities, fostering market growth. Moreover, the increasing focus on personalized medicine and the expansion of telepathology services, which enable remote diagnosis and consultation, create new avenues for market expansion.

Market Restraints:

Despite promising growth prospects, the digital pathology market faces challenges related to high implementation costs, data security concerns, and regulatory compliance. The initial investment required for digital pathology systems, including scanners, software, and IT infrastructure, can be significant, posing a barrier to adoption, particularly for small and mid-sized laboratories. Additionally, ensuring the security and confidentiality of digital pathology data is critical, given the sensitivity of patient information. Regulatory standards and compliance requirements vary across regions, adding complexity to market entry and operational processes. Addressing these economic and regulatory barriers necessitates collaboration between industry stakeholders and policymakers to promote access to secure and cost-effective digital pathology solutions.

Market Opportunities:

The digital pathology market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of AI and ML technologies in digital pathology enhances diagnostic accuracy, automates routine tasks, and facilitates predictive analytics, opening new frontiers in precision medicine. The growing trend of telepathology, driven by advancements in telecommunication infrastructure and the need for remote diagnostic solutions, expands the market reach and accessibility. Strategic partnerships, investment in research and development, and the introduction of user-friendly, interoperable digital pathology systems are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic digital pathology landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the digital pathology market globally?
  • Which systems and applications are driving digital pathology adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the digital pathology market?
  • Who are the key players contributing to the digital pathology market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global digital pathology market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital pathology market, including Leica Biosystems, Philips Healthcare, and Roche Diagnostics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced digital pathology solutions, including AI-powered image analysis software, high-throughput scanners, and cloud-based platforms, catering to diverse clinical and research needs. Collaborations with healthcare providers, academic institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and pathologist education fosters market growth and enhances diagnostic outcomes in the rapidly evolving digital pathology landscape.

Key Companies Profiled:

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm
  • OptraSCAN, Inc.
  • Inspirata, Inc.
  • Sectra AB

Digital Pathology Market Research Segmentation

By Product Type:

  • Digital Pathology Equipment
  • Digital Pathology Software
  • Digital Pathology Services

By Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic & Applied Research
  • Drug Development

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Digital Pathology Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Type Lifecycle Analysis
  • 2.4. Digital Pathology Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn ) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019-2023
    • 3.2.2. Current Market Size Forecast, 2024-2031
  • 3.3. Global Digital Pathology Market Outlook: Product Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Product Type, 2019-2023
    • 3.3.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
      • 3.3.3.1. Digital Pathology Equipment
        • 3.3.3.1.1. Whole Slide Scanners
        • 3.3.3.1.1.1. Brightfield Slide Scanners
        • 3.3.3.1.1.2. Fluorescence Slide Scanners
        • 3.3.3.1.1.3. Combination Slide Scanners
        • 3.3.3.1.2. Clinical Microscope
        • 3.3.3.1.3. Tissue Microarrays
      • 3.3.3.2. Digital Pathology Software
        • 3.3.3.2.1. Image Viewing and Analysis Software
        • 3.3.3.2.1.1. On-premise
        • 3.3.3.2.1.2. Cloud-based
        • 3.3.3.2.2. Digital Pathology Information Systems
        • 3.3.3.2.2.1. On-premise
        • 3.3.3.2.2.2. Cloud-based
      • 3.3.3.3. Digital Pathology Services
        • 3.3.3.3.1. Installation and Integration Services
        • 3.3.3.3.2. Consulting Services
        • 3.3.3.3.3. Maintenance and Validation Services
  • 3.4. Market Attractiveness Analysis: Product Type
  • 3.5. Global Digital Pathology Market Outlook: Application
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Application, 2019-2023
    • 3.5.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
      • 3.5.3.1. Clinical Pathology
      • 3.5.3.2. Molecular Diagnostics
      • 3.5.3.3. Basic & Applied Research
      • 3.5.3.4. Drug Development
      • 3.5.3.5. Others
  • 3.6. Market Attractiveness Analysis: Application
  • 3.7. Global Digital Pathology Market Outlook: End User
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By End User, 2019-2023
    • 3.7.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
      • 3.7.3.1. Hospitals
      • 3.7.3.2. Diagnostic Laboratories
      • 3.7.3.3. Pharmaceutical & Biotechnology Companies
      • 3.7.3.4. Forensic Laboratories
      • 3.7.3.5. Research Institutes
      • 3.7.3.6. Contract Research Organizations (CROs)
      • 3.7.3.7. Clinics
  • 3.8. Market Attractiveness Analysis: End User

4. Global Digital Pathology Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Region, 2019-2023
  • 4.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Region, 2024-2031
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 5.3.1. By Country
    • 5.3.2. By Product Type
    • 5.3.3. By Application
    • 5.3.4. By End User
  • 5.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 5.5.1. Digital Pathology Equipment
      • 5.5.1.1. Whole Slide Scanners
        • 5.5.1.1.1. Brightfield Slide Scanners
        • 5.5.1.1.2. Fluorescence Slide Scanners
        • 5.5.1.1.3. Combination Slide Scanners
      • 5.5.1.2. Clinical Microscope
      • 5.5.1.3. Tissue Microarrays
    • 5.5.2. Digital Pathology Software
      • 5.5.2.1. Image Viewing and Analysis Software
        • 5.5.2.1.1. On-premise
        • 5.5.2.1.2. Cloud-based
      • 5.5.2.2. Digital Pathology Information Systems
        • 5.5.2.2.1. On-premise
        • 5.5.2.2.2. Cloud-based
    • 5.5.3. Digital Pathology Services
      • 5.5.3.1. Installation and Integration Services
      • 5.5.3.2. Consulting Services
      • 5.5.3.3. Maintenance and Validation Services
  • 5.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 5.6.1. Clinical Pathology
    • 5.6.2. Molecular Diagnostics
    • 5.6.3. Basic & Applied Research
    • 5.6.4. Drug Development
    • 5.6.5. Others
  • 5.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 5.7.1. Hospitals
    • 5.7.2. Diagnostic Laboratories
    • 5.7.3. Pharmaceutical & Biotechnology Companies
    • 5.7.4. Forensic Laboratories
    • 5.7.5. Research Institutes
    • 5.7.6. Contract Research Organizations (CROs)
    • 5.7.7. Clinics
  • 5.8. Market Attractiveness Analysis

6. Europe Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By Application
    • 6.3.4. By End User
  • 6.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 6.5.1. Digital Pathology Equipment
      • 6.5.1.1. Whole Slide Scanners
        • 6.5.1.1.1. Brightfield Slide Scanners
        • 6.5.1.1.2. Fluorescence Slide Scanners
        • 6.5.1.1.3. Combination Slide Scanners
      • 6.5.1.2. Clinical Microscope
      • 6.5.1.3. Tissue Microarrays
    • 6.5.2. Digital Pathology Software
      • 6.5.2.1. Image Viewing and Analysis Software
        • 6.5.2.1.1. On-premise
        • 6.5.2.1.2. Cloud-based
      • 6.5.2.2. Digital Pathology Information Systems
        • 6.5.2.2.1. On-premise
        • 6.5.2.2.2. Cloud-based
    • 6.5.3. Digital Pathology Services
      • 6.5.3.1. Installation and Integration Services
      • 6.5.3.2. Consulting Services
      • 6.5.3.3. Maintenance and Validation Services
  • 6.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 6.6.1. Clinical Pathology
    • 6.6.2. Molecular Diagnostics
    • 6.6.3. Basic & Applied Research
    • 6.6.4. Drug Development
    • 6.6.5. Others
  • 6.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 6.7.1. Hospitals
    • 6.7.2. Diagnostic Laboratories
    • 6.7.3. Pharmaceutical & Biotechnology Companies
    • 6.7.4. Forensic Laboratories
    • 6.7.5. Research Institutes
    • 6.7.6. Contract Research Organizations (CROs)
    • 6.7.7. Clinics
  • 6.8. Market Attractiveness Analysis

7. East Asia Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By Application
    • 7.3.4. By End User
  • 7.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 7.5.1. Digital Pathology Equipment
      • 7.5.1.1. Whole Slide Scanners
        • 7.5.1.1.1. Brightfield Slide Scanners
        • 7.5.1.1.2. Fluorescence Slide Scanners
        • 7.5.1.1.3. Combination Slide Scanners
      • 7.5.1.2. Clinical Microscope
      • 7.5.1.3. Tissue Microarrays
    • 7.5.2. Digital Pathology Software
      • 7.5.2.1. Image Viewing and Analysis Software
        • 7.5.2.1.1. On-premise
        • 7.5.2.1.2. Cloud-based
      • 7.5.2.2. Digital Pathology Information Systems
        • 7.5.2.2.1. On-premise
        • 7.5.2.2.2. Cloud-based
    • 7.5.3. Digital Pathology Services
      • 7.5.3.1. Installation and Integration Services
      • 7.5.3.2. Consulting Services
      • 7.5.3.3. Maintenance and Validation Services
  • 7.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 7.6.1. Clinical Pathology
    • 7.6.2. Molecular Diagnostics
    • 7.6.3. Basic & Applied Research
    • 7.6.4. Drug Development
    • 7.6.5. Others
  • 7.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 7.7.1. Hospitals
    • 7.7.2. Diagnostic Laboratories
    • 7.7.3. Pharmaceutical & Biotechnology Companies
    • 7.7.4. Forensic Laboratories
    • 7.7.5. Research Institutes
    • 7.7.6. Contract Research Organizations (CROs)
    • 7.7.7. Clinics
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 8.5.1. Digital Pathology Equipment
      • 8.5.1.1. Whole Slide Scanners
        • 8.5.1.1.1. Brightfield Slide Scanners
        • 8.5.1.1.2. Fluorescence Slide Scanners
        • 8.5.1.1.3. Combination Slide Scanners
      • 8.5.1.2. Clinical Microscope
      • 8.5.1.3. Tissue Microarrays
    • 8.5.2. Digital Pathology Software
      • 8.5.2.1. Image Viewing and Analysis Software
        • 8.5.2.1.1. On-premise
        • 8.5.2.1.2. Cloud-based
      • 8.5.2.2. Digital Pathology Information Systems
        • 8.5.2.2.1. On-premise
        • 8.5.2.2.2. Cloud-based
    • 8.5.3. Digital Pathology Services
      • 8.5.3.1. Installation and Integration Services
      • 8.5.3.2. Consulting Services
      • 8.5.3.3. Maintenance and Validation Services
  • 8.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 8.6.1. Clinical Pathology
    • 8.6.2. Molecular Diagnostics
    • 8.6.3. Basic & Applied Research
    • 8.6.4. Drug Development
    • 8.6.5. Others
  • 8.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 8.7.1. Hospitals
    • 8.7.2. Diagnostic Laboratories
    • 8.7.3. Pharmaceutical & Biotechnology Companies
    • 8.7.4. Forensic Laboratories
    • 8.7.5. Research Institutes
    • 8.7.6. Contract Research Organizations (CROs)
    • 8.7.7. Clinics
  • 8.8. Market Attractiveness Analysis

9. Latin America Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 9.5.1. Digital Pathology Equipment
      • 9.5.1.1. Whole Slide Scanners
        • 9.5.1.1.1. Brightfield Slide Scanners
        • 9.5.1.1.2. Fluorescence Slide Scanners
        • 9.5.1.1.3. Combination Slide Scanners
      • 9.5.1.2. Clinical Microscope
      • 9.5.1.3. Tissue Microarrays
    • 9.5.2. Digital Pathology Software
      • 9.5.2.1. Image Viewing and Analysis Software
        • 9.5.2.1.1. On-premise
        • 9.5.2.1.2. Cloud-based
      • 9.5.2.2. Digital Pathology Information Systems
        • 9.5.2.2.1. On-premise
        • 9.5.2.2.2. Cloud-based
    • 9.5.3. Digital Pathology Services
      • 9.5.3.1. Installation and Integration Services
      • 9.5.3.2. Consulting Services
      • 9.5.3.3. Maintenance and Validation Services
  • 9.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 9.6.1. Clinical Pathology
    • 9.6.2. Molecular Diagnostics
    • 9.6.3. Basic & Applied Research
    • 9.6.4. Drug Development
    • 9.6.5. Others
  • 9.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 9.7.1. Hospitals
    • 9.7.2. Diagnostic Laboratories
    • 9.7.3. Pharmaceutical & Biotechnology Companies
    • 9.7.4. Forensic Laboratories
    • 9.7.5. Research Institutes
    • 9.7.6. Contract Research Organizations (CROs)
    • 9.7.7. Clinics
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Application
    • 10.3.4. By End User
  • 10.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 10.5.1. Digital Pathology Equipment
      • 10.5.1.1. Whole Slide Scanners
        • 10.5.1.1.1. Brightfield Slide Scanners
        • 10.5.1.1.2. Fluorescence Slide Scanners
        • 10.5.1.1.3. Combination Slide Scanners
      • 10.5.1.2. Clinical Microscope
      • 10.5.1.3. Tissue Microarrays
    • 10.5.2. Digital Pathology Software
      • 10.5.2.1. Image Viewing and Analysis Software
        • 10.5.2.1.1. On-premise
        • 10.5.2.1.2. Cloud-based
      • 10.5.2.2. Digital Pathology Information Systems
        • 10.5.2.2.1. On-premise
        • 10.5.2.2.2. Cloud-based
    • 10.5.3. Digital Pathology Services
      • 10.5.3.1. Installation and Integration Services
      • 10.5.3.2. Consulting Services
      • 10.5.3.3. Maintenance and Validation Services
  • 10.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 10.6.1. Clinical Pathology
    • 10.6.2. Molecular Diagnostics
    • 10.6.3. Basic & Applied Research
    • 10.6.4. Drug Development
    • 10.6.5. Others
  • 10.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 10.7.1. Hospitals
    • 10.7.2. Diagnostic Laboratories
    • 10.7.3. Pharmaceutical & Biotechnology Companies
    • 10.7.4. Forensic Laboratories
    • 10.7.5. Research Institutes
    • 10.7.6. Contract Research Organizations (CROs)
    • 10.7.7. Clinics
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Product Type Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Danaher Corporation
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product Type
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. F. Hoffmann-La Roche AG
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product Type
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Huron Technologies International Inc.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product Type
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Koninklijke Philips N.V.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product Type
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Olympus Corporation
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product Type
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Hamamatsu Photonics K.K.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product Type
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Carl Zeiss AG
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product Type
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Nikon Corporation
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product Type
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. 3DHISTECH Ltd.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product Type
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Hologic Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product Type
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. PerkinElmer, Inc.
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product Type
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. Visiopharm
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product Type
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. OptraSCAN, Inc.
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product Type
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. Inspirata, Inc.
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product Type
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. Sectra AB
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product Type
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations